At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
TempSure Firmdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Histological Study to Assess Safety and Efficacy of the TempSure Firm for Non-Invasive Lipolysis
In Brief
A clinical study evaluating TempSure Firm for Non-invasive Lipolysis. Completed, enrolled 9 participants across 2 sites.
Detailed Summary
This is a prospective, open-labeled, non-randomized, multi-center clinical study to collect safety and efficacy data on the TempSure Firm. The intended use of the TempSure device is to use the Firm handpieces for non-invasive lipolysis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-invasive Lipolysis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedMay 2021
Primary CompletionSep 2021
TodayJul 2026
First PostedMay 7, 2021
Enrollment StartMar 12, 2021
Primary CompletionSep 28, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.2 years ago
Interventions
TempSure Firmdevice
The TempSure firm will be used on the abdomen for non-invasive lipolysis.